• 1985

Company Description

SR One is the corporate venture capital arm of GlaxoSmithKline.

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care. Since 1985, SR One has invested approximately 800 million in more than 180 companies. For more information please visit www.srone.com